254 related articles for article (PubMed ID: 28282438)
1. A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles.
Lee AL; Ung HM; Sands LP; Kikis EA
PLoS One; 2017; 12(3):e0173644. PubMed ID: 28282438
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
3. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
4. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.
Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM
Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481
[TBL] [Abstract][Full Text] [Related]
6. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.
Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ
Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334
[TBL] [Abstract][Full Text] [Related]
7. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA
EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223
[TBL] [Abstract][Full Text] [Related]
8. G3BP1-dependent mechanism suppressing protein aggregation in Huntington's models and its demise upon stress granule assembly.
GutiƩrrez-Garcia R; Koyuncu S; Hommen F; Bilican S; Lee HJ; Fatima A; Vilchez D
Hum Mol Genet; 2023 May; 32(10):1607-1621. PubMed ID: 36611004
[TBL] [Abstract][Full Text] [Related]
9. Proteostasis of Huntingtin in Health and Disease.
Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
[TBL] [Abstract][Full Text] [Related]
10. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
11. The polyglutamine domain is the primary driver of seeding in huntingtin aggregation.
Skeens A; Siriwardhana C; Massinople SE; Wunder MM; Ellis ZL; Keith KM; Girman T; Frey SL; Legleiter J
PLoS One; 2024; 19(3):e0298323. PubMed ID: 38483973
[TBL] [Abstract][Full Text] [Related]
12. Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model system.
Xi W; Wang X; Laue TM; Denis CL
Sci Rep; 2016 Oct; 6():34916. PubMed ID: 27721444
[TBL] [Abstract][Full Text] [Related]
13. Novel polyglutamine model uncouples proteotoxicity from aging.
Christie NT; Lee AL; Fay HG; Gray AA; Kikis EA
PLoS One; 2014; 9(5):e96835. PubMed ID: 24817148
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron.
Faber PW; Alter JR; MacDonald ME; Hart AC
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):179-84. PubMed ID: 9874792
[TBL] [Abstract][Full Text] [Related]
15. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
[TBL] [Abstract][Full Text] [Related]
16. Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.
Daldin M; Fodale V; Cariulo C; Azzollini L; Verani M; Martufi P; Spiezia MC; Deguire SM; Cherubini M; Macdonald D; Weiss A; Bresciani A; Vonsattel JG; Petricca L; Marsh JL; Gines S; Santimone I; Marano M; Lashuel HA; Squitieri F; Caricasole A
Sci Rep; 2017 Jul; 7(1):5070. PubMed ID: 28698602
[TBL] [Abstract][Full Text] [Related]
17. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
[TBL] [Abstract][Full Text] [Related]
18. Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity.
Wang Q; Zhang J; Jiang Y; Xiao Y; Li X; Mao X; Huang Z
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34633391
[TBL] [Abstract][Full Text] [Related]
19. Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers.
Posey AE; Ruff KM; Harmon TS; Crick SL; Li A; Diamond MI; Pappu RV
J Biol Chem; 2018 Mar; 293(10):3734-3746. PubMed ID: 29358329
[TBL] [Abstract][Full Text] [Related]
20. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19.
He WT; Xue W; Gao YG; Hong JY; Yue HW; Jiang LL; Hu HY
Sci Rep; 2017 Nov; 7(1):14797. PubMed ID: 29093475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]